Seasonal Influenza Vaccination Resources for Health Professionals (CDC): HERE
SELF Magazine and the American Academy of Pediatrics recently updated the stock photos of immunizations. Check them out here.
ACIP Recommendations for the 2019-2020 Influenza Season
Read the whole report here.
This report updates the 2018–19 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2018;67[No. RR-3]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. A licensed, recommended, and age-appropriate vaccine should be used. Inactivated influenza vaccines (IIVs), recombinant influenza vaccine (RIV), and live attenuated influenza vaccine (LAIV) are expected to be available for the 2019–20 season. Standard-dose, unadjuvanted, inactivated influenza vaccines will be available in quadrivalent formulations (IIV4s). High-dose (HD-IIV3) and adjuvanted (aIIV3) inactivated influenza vaccines will be available in trivalent formulations. Recombinant (RIV4) and live attenuated influenza vaccine (LAIV4) will be available in quadrivalent formulations.
Trivalent Vaccine Composition:
- H1N1 pdm09-like virus: A/Brisbane/02/2018
- H3N2-like virus: A/Kansas/14/2017
- Victoria Lineage: B/Colorado/06/2017-like virus
Quadrivalent Vaccines will also contain:
- Yamagata Lineage: B/Phuket/3073/2013-like virus
CDC Launches New Pneumococcal Vaccination App
As influenza activity picks up, we may also see increases in pneumococcal disease rates. Help protect your patients by making sure they are up to date with pneumococcal vaccination. CDC recently launched an app to help vaccination providers quickly and easily determine which pneumococcal vaccines a patient needs and when. The PneumoRecs VaxAdvisor mobile app incorporates recommendations for all ages and will especially help with interpreting vaccination recommendations based on medical indications. Users simply enter a patient’s age, note if the patient has specific underlying medical conditions, and answer questions about the patient’s pneumococcal vaccination history. Then the app provides patient-specific guidance consistent with U.S. Advisory Committee on Immunization Practices recommended immunization schedule.
Available for iOS and Android devices at cdc.gov/vaccines/pneumoapp